Delivery Order SPE2DB22D9207-SPE2DB24FH4YP
Award Date 3/25/24
Potential Completion Date 3/26/24
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,807.43 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of Jakafi 25 mg tablet prescription drugs. The award was made under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB24FPQH2 with DLA, which has a potential ceiling value of $4,999,999 and supports the recurring pharmaceutical supply needs of military health facilities worldwide. DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,300.73 contract is to provide the DLA with 4,556,044,091 units of the drug Jakafi 10 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue firm fixed-price orders for a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,773.87, is for the delivery of 4564859930 - Jakafi 15 mg Tablet 60s to support the medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,773.87 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,564,197 units of the 15 mg Jakafi tablet. This delivery order is part of DMS Pharmaceutical Group's larger $4,999,999 indefinite delivery vehicle (IDV) contract with DLA, contract number 4600082013 under the SPE2DB program, which enables DLA to issue delivery orders for a broad range of pharmaceutical products to...
- This is a $80,427.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The order is for 4556396641 Jakafi 10 mg tablets, a specialty medication. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $94,761.88 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through March 11, 2024, is for the delivery of 4,563,904,762 units of the pharmaceutical drug Jakafi 5 mg tablets. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the...
- The Defense Logistics Agency awarded a delivery order valued at $11,999.80 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 15 mg tablets (60-count units). This contract is not set-aside designated and carries a firm fixed-price structure with an ultimate completion date of September 3, 2025. The delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 and valid through November 2026, which enables the agency to procure...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 4,563,652,559 tablets of the pharmaceutical product Jakafi 5 mg. The $12,296.20 contract has a completion date of February 2, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with the Defense Logistics Agency, valued at up to $4,999,999 through 2025, to deliver a wide range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, provides for the delivery of Jakafi 15 mg tablets to support the medical supply needs of U.S. government agencies, particularly the Department of Defense. This Delivery Order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Jakafi 10 mg tablets. The contract has a ceiling value of $48,462.60 and an ultimate completion date of March 31, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency...